Publicly Listed BioSig Merges with Streamex, Plans to Raise $1.1 Billion to Advance RWA Tokenization Development

On July 8, BioSig Technologies, a U.S. Nasdaq-listed medical device technology company, announced that it has merged with Streamex Exchange Corporation, another Nasdaq-listed company, and also signed a financing agreement of up to $1.1 billion to promote the development of RWA tokenization business, promote the on-chaining of the $142 trillion commodity market, and focus on gold tokenization.

The company will sell $100 million worth of senior secured convertible bonds and a $1 billion equity credit line. The transaction is co-led by Cantor Fitzgerald, the asset custodian of Tether.

Streamex is a wholly-owned subsidiary of BioSig Technologies, Inc. and is a real-world asset (RWA) tokenization company focused on the commodity sector. Streamex's goal is to put the commodity market on-chain and has developed key issuance and trading infrastructure that will revolutionize commodity finance. [BlockBeats]